Clinical Trials · NCT04143802
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 72
- Start date
- Dec 2019
- Locations
- 4 sites, United States
- Primary endpoint
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration